Trial record 2 of 615 for:
Cerebral Palsy and Sleep Apnea in North Part of Finland
The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2013 by University of Oulu.
Recruitment status was Recruiting
Information provided by (Responsible Party):
University of Oulu
First received: May 21, 2013
Last updated: May 22, 2013
Last verified: May 2013
Obstructive sleep apnoea is a risk factor for cerebral palsy. study hypothesis: In prospective study the investigators want to know how many cerebral palsy patients have sleep apnoea and does thrombolysis play a role in severity of osa in six months follow up.
||Observational Model: Case Control
Time Perspective: Prospective
|Target Follow-Up Duration:
||Obstructive Sleep Apnea as a Risk Factor for Cerebral Palsy, a Prospective Study
Primary Outcome Measures:
| Estimated Enrollment:
| Study Start Date:
| Estimated Study Completion Date:
| Estimated Primary Completion Date:
||April 2014 (Final data collection date for primary outcome measure)
Nasal-cpap treatment and compliance in sleep apnea patients with cerebral palsy.
No Nasal-cpap treatment in sleep apnea patients with cerebral palsy. Severity of sleep apnea in thrombolysis patients and in control patients. Thrombolysis reduces severity of sleep apnea.Sleep apnea is common among cerebral palsy patients.
No nasal-cpap in sleep apnea patients with cerebral palsy
In prospective study the investigators include all over 18 years old patients who came to emergency room for cerebral palsy.Exclusion criteria is not able to co-operate or need for intensive care unit.The investigators shall take 100 control patients who have cerebral palsy and no thrombolysis and 100 study patients who will have thrombolysis. The investigators do sleep registration during hospital staying within 2 days after patients have felt ill.Follow-up registration will be done after 6 months at home.
|Ages Eligible for Study:
||18 Years and older
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
residents of Oulu university hospital area. consecutive patient sampling
- over 18 years old patients that have cerebral palsy and are able to participate to the study.
- no co-operation and need for intensive care unit
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01861275
University of Oulu
||Tarja Saaresranta, Md PhD
||University hospital of Turku
||University of Oulu
History of Changes
|Other Study ID Numbers:
|Study First Received:
||May 21, 2013
||May 22, 2013
||Finland: Ethics Committee
Keywords provided by University of Oulu:
thrombolysis in cerebral palsy
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on May 02, 2016
Brain Damage, Chronic
Sleep Apnea Syndromes
Central Nervous System Diseases
Nervous System Diseases
Respiratory Tract Diseases
Signs and Symptoms
Signs and Symptoms, Respiratory
Sleep Disorders, Intrinsic